SRDX
Price
$29.99
Change
+$0.99 (+3.41%)
Updated
Jul 3 closing price
Capitalization
397.04M
26 days until earnings call
TFX
Price
$119.90
Change
-$1.69 (-1.39%)
Updated
Jul 3 closing price
Capitalization
10.49B
20 days until earnings call
Interact to see
Advertisement

SRDX vs TFX

Header iconSRDX vs TFX Comparison
Open Charts SRDX vs TFXBanner chart's image
Surmodics
Price$29.99
Change+$0.99 (+3.41%)
Volume$140.85K
Capitalization397.04M
Teleflex
Price$119.90
Change-$1.69 (-1.39%)
Volume$360.06K
Capitalization10.49B
SRDX vs TFX Comparison Chart in %
Loading...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRDX vs. TFX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRDX is a Hold and TFX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (SRDX: $29.99 vs. TFX: $119.90)
Brand notoriety: SRDX and TFX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SRDX: 177% vs. TFX: 67%
Market capitalization -- SRDX: $397.04M vs. TFX: $10.49B
SRDX [@Medical Specialties] is valued at $397.04M. TFX’s [@Medical Specialties] market capitalization is $10.49B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRDX’s FA Score shows that 0 FA rating(s) are green whileTFX’s FA Score has 1 green FA rating(s).

  • SRDX’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, TFX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRDX’s TA Score shows that 7 TA indicator(s) are bullish while TFX’s TA Score has 5 bullish TA indicator(s).

  • SRDX’s TA Score: 7 bullish, 2 bearish.
  • TFX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, SRDX is a better buy in the short-term than TFX.

Price Growth

SRDX (@Medical Specialties) experienced а +3.09% price change this week, while TFX (@Medical Specialties) price change was +0.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

SRDX is expected to report earnings on Jul 30, 2025.

TFX is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TFX($10.5B) has a higher market cap than SRDX($397M). SRDX has higher P/E ratio than TFX: SRDX (71.51) vs TFX (29.48). SRDX YTD gains are higher at: -26.768 vs. TFX (-31.330). TFX has higher annual earnings (EBITDA): 761M vs. SRDX (22.1M). TFX has more cash in the bank: 223M vs. SRDX (35.2M). SRDX has less debt than TFX: SRDX (33.9M) vs TFX (1.93B). TFX has higher revenues than SRDX: TFX (2.97B) vs SRDX (138M).
SRDXTFXSRDX / TFX
Capitalization397M10.5B4%
EBITDA22.1M761M3%
Gain YTD-26.768-31.33085%
P/E Ratio71.5129.48243%
Revenue138M2.97B5%
Total Cash35.2M223M16%
Total Debt33.9M1.93B2%
FUNDAMENTALS RATINGS
SRDX vs TFX: Fundamental Ratings
SRDX
TFX
OUTLOOK RATING
1..100
6111
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9386
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
9442
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (14) in the Medical Specialties industry is significantly better than the same rating for SRDX (92). This means that TFX’s stock grew significantly faster than SRDX’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

TFX's SMR Rating (86) in the Medical Specialties industry is in the same range as SRDX (93). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's Price Growth Rating (63) in the Medical Specialties industry is in the same range as TFX (64). This means that SRDX’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for SRDX (94). This means that TFX’s stock grew somewhat faster than SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRDXTFX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
53%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 19 days ago
67%
Bullish Trend 15 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 5 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
65%
Aroon
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVTK5.750.75
+15.00%
Eventiko Inc.
BBXIA3.300.10
+3.12%
BBX Capital, Inc.
SAFRY78.700.24
+0.31%
Safran SA
GYUAF17.50N/A
N/A
Gs Yuasa Corp.
ASGLY5.62-0.16
-2.85%
AGC Inc.

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-0.96%
PXMBF - SRDX
41%
Loosely correlated
N/A
BDX - SRDX
30%
Poorly correlated
-0.23%
TFX - SRDX
30%
Poorly correlated
-0.20%
BLCO - SRDX
30%
Poorly correlated
+2.30%
SHC - SRDX
28%
Poorly correlated
+1.66%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
-0.20%
A - TFX
50%
Loosely correlated
+0.17%
RVTY - TFX
46%
Loosely correlated
+1.89%
WAT - TFX
45%
Loosely correlated
-1.43%
TNDM - TFX
45%
Loosely correlated
-0.93%
BDX - TFX
43%
Loosely correlated
-0.23%
More